FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:1927 June 25, 1998 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

To the Editor: The letter by Spingarn and Benjamin and the reply by Meissner (March 5 issue)^1,2 highlight problems with the discussion about the merits of universal varicella immunization. All parties agree that the vaccine is safe and effective and that nonimmune adults and high-risk children require immunization. Beyond that, both sides expend considerable energy talking past one another. For example, with regard to the morbidity and mortality associated with varicella, the authors cite the same statistics to support opposite claims: that childhood varicella infection does or does not merit a universal immunization program. This "yes, it is" "no, it . . . [Full Text of this Article]

References

Related Letters:

Universal Vaccination against Varicella
Spingarn R. W., Benjamin J. A., Meissner H. C.
Extract | Full Text  
N Engl J Med 1998; 338:683-684, Mar 5, 1998. Correspondence

This article has been cited by other articles:

• Goldman, G. S. (2005). Universal Varicella Vaccination: Efficacy Trends and Effect on Herpes Zoster. International Journal of Toxicology 24: 205-213 [Abstract] [Full Text]  
• Davis, M. M., Patel, M. S., Gebremariam, A. (2004). Decline in Varicella-Related Hospitalizations and Expenditures for Children and Adults After Introduction of Varicella Vaccine in the United States. Pediatrics 114: 786-792 [Abstract] [Full Text]